The problem of protocol driven costs in pharmacoeconomic analysis.

This publication has 35 references indexed in Scilit:

• Explanatory and pragmatic attitudes in therapeutical trials
  Published by Elsevier ,2004
• Exorcising Protocol-induced Spirits:
  Medical Decision Making, 1997
• A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials
  PharmacoEconomics, 1996
• Cost‐effectiveness of blood transfusion and white cell reduction in elective colorectal surgery
  Transfusion, 1995
• Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trial
  The Journal of Pediatrics, 1995
• Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: Impact on hospital resource use and charges
  The Journal of Pediatrics, 1995
• Enhanced low density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy
  The American Journal of Cardiology, 1995
• Clinical studies to assess the economic impact of new therapies: pragmatic approaches to measuring costs
  Anti-Cancer Drugs, 1993
• Does expenditure on pharmaceuticals give good value for money?: current evidence and policy implications
  Health Policy, 1993
• Economic Analysis in Randomized Control Trials
  Medical Care, 1992